Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197–210.
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke Statistics-2022 update: A report from the American heart association. Circulation. 2022;145(8):e153–639.
Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obes (Silver Spring). 2014;22(1):110–8.
Wakabayashi I, Daimon T. The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274–8.
Article CAS PubMed Google Scholar
Higashiyama A, Wakabayashi I, Okamura T, et al. The risk of fasting triglycerides and its related indices for ischemic cardiovascular diseases in Japanese community dwellers: the suita study. J Atheroscler Thromb. 2021;28(12):1275–88.
Article PubMed PubMed Central Google Scholar
Lazzer S, D’Alleva M, Isola M, et al. Cardiometabolic index (CMI) and visceral adiposity index (VAI) highlight a higher risk of metabolic syndrome in women with severe obesity. J Clin Med. 2023;12(9):3055.
Article CAS PubMed PubMed Central Google Scholar
Aguirre AD, Arbab-Zadeh A, Soeda T, Fuster V, Jang IK. Optical coherence tomography of plaque vulnerability and rupture: JACC focus seminar part 1/3. J Am Coll Cardiol. 2021;78(12):1257–65.
Article PubMed PubMed Central Google Scholar
Araki M, Yonetsu T, Kurihara O, et al. Predictors of rapid plaque progression: an optical coherence tomography study. JACC Cardiovasc Imaging. 2021;14(8):1628–38.
Gusev E, Sarapultsev A. Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci. 2023;24(9):7910.
Article CAS PubMed PubMed Central Google Scholar
Yuki H, Sugiyama T, Suzuki K, et al. Coronary inflammation and plaque vulnerability: A coronary computed tomography and optical coherence tomography study. Circ Cardiovasc Imaging. 2023;16(3):e014959.
Waksman R, Merdler I, Case BC, Waksman O, Porto I. Targeting inflammation in atherosclerosis: overview, strategy and directions. EuroIntervention. 2024;20(1):32–44.
Article PubMed PubMed Central Google Scholar
Mariaca K, Serés-Noriega T, Viñals C, et al. Neutrophil-to-lymphocyte ratio is independently associated with carotid atherosclerosis burden in individuals with type 1 diabetes. Nutr Metab Cardiovasc Dis. 2024;34(2):395–403.
Article CAS PubMed Google Scholar
Qi L, Li Y, Kong C, et al. Morphological changes of Peri-Coronary adipose tissue together with elevated NLR in acute myocardial infarction patients in-Hospital. J Inflamm Res. 2024;17:4065–76.
Article PubMed PubMed Central Google Scholar
Xu B, Wu Q, La R, et al. Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study. Cardiovasc Diabetol. 2024;23(1):212.
Article CAS PubMed PubMed Central Google Scholar
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826.
Article CAS PubMed Google Scholar
Araki M, Park SJ, Dauerman HL, et al. Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol. 2022;19(10):684–703.
Article PubMed PubMed Central Google Scholar
Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–9.
Article CAS PubMed Google Scholar
Zha F, Cao C, Hong M, et al. The nonlinear correlation between the cardiometabolic index and the risk of diabetes: A retrospective Japanese cohort study. Front Endocrinol (Lausanne). 2023;14:1120277.
Liu X, Wu Q, Yan G, et al. Cardiometabolic index: a new tool for screening the metabolically obese normal weight phenotype. J Endocrinol Invest. 2021;44(6):1253–61.
Article CAS PubMed Google Scholar
Zhuo L, Lai M, Wan L, Zhang X, Chen R. Cardiometabolic index and the risk of new-onset chronic diseases: results of a National prospective longitudinal study. Front Endocrinol (Lausanne). 2024;15:1446276.
Chen X, Zhao Y, Sun J, Jiang Y, Tang Y. Identification of metabolic syndrome using lipid accumulation product and cardiometabolic index based on NHANES data from 2005 to 2018. Nutr Metab (Lond). 2024;21(1):96.
Article CAS PubMed Google Scholar
Tamini S, Bondesan A, Caroli D, Sartorio A. The lipid accumulation product index (LAP) and the cardiometabolic index (CMI) are useful for predicting the presence and severity of metabolic syndrome in adult patients with obesity. J Clin Med. 2024;13(10):2843.
Article CAS PubMed PubMed Central Google Scholar
Gonzalez-Chávez A, Chávez-Fernández JA, Elizondo-Argueta S, González-Tapia A, León-Pedroza JI, Ochoa C. Metabolic syndrome and cardiovascular disease: A health challenge. Arch Med Res. 2018;49(8):516–21.
Xu J, Kitada M, Ogura Y, Koya D. Relationship between autophagy and metabolic syndrome characteristics in the pathogenesis of atherosclerosis. Front Cell Dev Biol. 2021;9:641852.
Article PubMed PubMed Central Google Scholar
Merkin SS, Karlamangla A, Elashoff D, Grogan T, Seeman T. Change in cardiometabolic score and incidence of cardiovascular disease: the multi-ethnic study of atherosclerosis. Ann Epidemiol. 2015;25(12):912–e71.
Article PubMed PubMed Central Google Scholar
Wakabayashi I, Sotoda Y, Hirooka S, Orita H. Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease. Clin Chim Acta. 2015;446:231–6.
Article CAS PubMed Google Scholar
Prati F, Romagnoli E, Gatto L, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41(3):383–91.
Jiang S, Fang C, Xu X, et al. Identification of High-Risk coronary lesions by 3-Vessel optical coherence tomography. J Am Coll Cardiol. 2023;81(13):1217–30.
Kedhi E, Berta B, Roleder T, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Eur Heart J. 2021;42(45):4671–9.
Article CAS PubMed Google Scholar
Gatto L, Alfonso F, Paoletti G, et al. Relationship betweeen the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study. Int J Cardiol. 2022;346:8–12.
Raffel OC, Tearney GJ, Gauthier DD, Halpern EF, Bouma BE, Jang IK. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol. 2007;27(8):1820–7.
Article CAS PubMed PubMed Central Google Scholar
Simion V, Zhou H, Haemmig S, et al. A macrophage-specific LncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. Nat Commun. 2020;11(1):6135.
Comments (0)